CIK 0001061983
- Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 943291317
- Phone
- +1 650-624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale EVP, Chief Financial Officer sold 38,730 shares at $82.30 ($3,187,479)
- 4 Planned sale EVP, Chief Financial Officer sold 3,134 shares at $85.00 ($266,390)
- 4 Planned sale EVP Research & Development sold 3,500 shares at $79.51 ($278,285)
- 4 Planned sale President & CEO sold 7,500 shares at $70.46 ($528,450)
- 4 Planned sale EVP Research & Development sold 3,500 shares at $67.98 ($237,930)
- 4 Planned sale Director sold 2,933 shares at $76.09 ($223,172)
- 4 Planned sale EVP, Chief Commercial Officer sold 15,000 shares at $74.08 ($1,111,200)
- 4 Planned sale Director sold 5,000 shares at $74.08 ($370,400)
- 4 Planned sale President & CEO sold 7,500 shares at $77.21 ($579,075)
- 4 Grant or award Director acquired 2,851 shares (grant or award)
- 4 Grant or award Director acquired 2,851 shares (grant or award)
- 4 Grant or award Director acquired 2,851 shares (grant or award)
- 4 Grant or award Director acquired 2,851 shares (grant or award)
- 4 Grant or award Director acquired 2,851 shares (grant or award)
- 4 Grant or award Director acquired 2,851 shares (grant or award)
- 4 Grant or award Director acquired 2,851 shares (grant or award)
- 4 Grant or award Director acquired 2,851 shares (grant or award)
- 4 Grant or award Director acquired 2,851 shares (grant or award)
- 4 Planned sale EVP Research & Development sold 3,500 shares at $75.69 ($264,915)
- 4 Planned sale President & CEO sold 7,500 shares at $77.92 ($584,400)
Page 3 of 70 · 1,399 filings